Effectiveness and cost-effectiveness of a multimodal programme as coadjuvant treatment in people with a diagnosis of long COVID-19 from primary health care: a randomised clinical trial

Instituto de Salud Carlos III0 个研究点目标入组 100 人开始时间: 2022年2月10日最近更新: 2024年7月8日

适应症

试验速览

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36612782/ (added 02/03/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37193738/ results (added 17/05/2023)

•Current participant inclusion criteria as of 11/03/2022:
•1. Individuals over the age of 18 years
•2. Suffering from long COVID-19
•3. From Primary Health Centers of Aragón (Spain)
•4. Understand written and spoken Spanish
•5. Have provided their informed consent
•6. Who are not undergoing training or rehabilitation through respiratory physiotherapy, physical activity, or cognitive stimulation
•Previous participant inclusion criteria:
•1. Individuals over the age of 18 years
•2. Suffering from long COVID-19
•3. From Primary Health Centers of Aragón (Spain)
•4. Understand written and spoken Spanish
•5. Have provided their informed consent

•1. Presence of serious uncontrolled medical illness, which may interfere with compliance with the activities and recommendations
•2. Risk of suicide
•3. Pregnancy or lactation
•4. Patients who have participated in another clinical trial over the past 6 months
•5. Are currently receiving structured psychotherapeutic treatment by a mental health professional over the past 6 months
•6. The presence of any medical, psychological or social problem that could seriously interfere with the patient’s participation in the study

发起方

Instituto de Salud Carlos III